EU approves Brio/Libra/LibraXP deep brain stimulation systems (St Jude Medical) for Dystonia

The EU has given CE Mark approval of the Brio, Libra and LibraXP deep brain stimulation (DBS) systems, from St Jude Medical, for managing the symptoms of intractable primary and secondary Dystonia, a neurological movement disorder that causes involuntarily spasm. This approval represents the first by a regulatory agency for the use of deep brain stimulation to manage both primary and secondary Dystonia.

DBS therapy for Dystonia involves the delivery of mild electrical pulses to a specific target in the brain. Stimulation is delivered to one of two regions, the subthalamic nucleus (STN) or the globus pallidus interna (GPi), areas of the brain involved with controlling movement. The Brio neurostimulator is the world�s smallest DBS device.